{
 "drug": "Tobramycin Sulfate Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "07/17/2026",
 "dayN": 39,
 "cat": "Anti-Infective",
 "companies": [
  "Hospira, Inc., a Pfizer Company"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "07/17/2026",
   "update_type": "New",
   "initial_posting_date": "07/17/2026",
   "package_ndc": "0409-3578-01",
   "generic_name": "Tobramycin Sulfate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA063111"
    ],
    "brand_name": [
     "TOBRAMYCIN"
    ],
    "generic_name": [
     "TOBRAMYCIN"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-3578"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "TOBRAMYCIN SULFATE"
    ],
    "rxcui": [
     "597823"
    ],
    "spl_id": [
     "d69232fd-aeae-44b9-9e43-2f2e5bd843be"
    ],
    "spl_set_id": [
     "c5a005b0-7b6f-4e30-df92-9a20b1ca66a1"
    ],
    "package_ndc": [
     "0409-3578-11",
     "0409-3578-01"
    ],
    "unii": [
     "HJT0RXD7JK"
    ]
   },
   "update_date": "07/17/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Tobramycin Sulfate, Injection, 80 mg/2 mL (40 mg/mL); 2 mL Multiple Dose Glass Fliptop Vial (NDC 0409-3578-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  }
 ]
}